News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Karen O. Moss, PhD, RN, CNL

Advertisement

Articles by Karen O. Moss, PhD, RN, CNL

Family Caregiver Satisfaction With End-of-Life Care Following Advanced Cancer

ByKaren O. Moss, PhD, RN, CNL,Sara L. Douglas, PhD, RN
March 21st 2018

Family caregiver satisfaction with end-of-life care is key to better understanding patient experiences.

Advertisement

Latest Updated Articles

  • Family Caregiver Satisfaction With End-of-Life Care Following Advanced Cancer
    Family Caregiver Satisfaction With End-of-Life Care Following Advanced Cancer

    Published: March 21st 2018 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Pirtobrutinib Wins Traditional FDA Approval in CLL and SLL

2

FDA Approves Liso-Cel in Pretreated R/R Marginal Zone Lymphoma

3

The AYA Oncology Nurse Navigator Role: What It Is and Why It Matters

4

Balancing Benefit and Toxicity in Adjuvant Therapy for Cervical Cancer

5

Which Cancer Therapies Were Approved by the FDA in November?

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us